1. The central nervous system:in mammals is able to react to painful s
timuli at many levels that are involved in transmission, modulation an
d sensation of pain. Endogenous opioid peptides and their receptors ar
e located at key points in pain pathways, and response to pain can be
modulated by local application of opioids at many sites. Mechanisms of
opioid analgesia at peripheral, spinal, medullary and midbrain levels
are only incompletely understood; forebrain systems are even less app
reciated. Local circuits in the spinal dorsal horn play a critical rol
e in processing nociceptive afferent input and in mediating the action
s of descending pain modulating systems. 2. The opioid receptors, rece
ntly cloned, exert their effects by activating G protein coupled effec
tor systems, such as ion channels and second messenger systems. Althou
gh the receptor most commonly associated with pain relief is the mu-re
ceptor, specific delta- and kappa-agonists can also mediate antinocice
ption at spinal and supraspinal sites. Acute effects of opioids on tar
get neurons are inhibitory, but excitatory effects have also been repo
rted. 3. Noxious stimulation increases neuronal activity and modulates
expression of genes, including immediate-early genes and neuropeptide
(i.e. opioid) genes at spinal and supraspinal levels of the somatosen
sory system. Opioid drugs and endogenously released opioid peptides ca
n modulate signal transduction mechanisms and intracellular processes
that lead to alterations in protein phosphorylation and gene expressio
n. These effects of opioids at the cellular level may underlie the mec
hanisms of pre-emptive analgesia and neuroplastic changes such as tole
rance, dependence, sensitization, hyperalgesia, adaptation, addiction,
and modulation of pain memories.